These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 43842)

  • 1. Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia.
    Baldessarini RJ; Tarsy D
    Int Rev Neurobiol; 1979; 21():1-45. PubMed ID: 43842
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic-induced tardive dyskinesia.
    Jenner P; Marsden CD
    Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiologic basis of tardive dyskinesia.
    Baldessarini RJ; Tarsy D
    Adv Biochem Psychopharmacol; 1980; 24():451-5. PubMed ID: 6105793
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neuroleptic-induced tardive dyskinesia: recent pathophysiological data, therapeutic trials (author's transl)].
    Gaillard-Sizaret C; Gaillard P
    Therapie; 1979; 34(5):555-74. PubMed ID: 44767
    [No Abstract]   [Full Text] [Related]  

  • 5. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tardive dyskinesia: a role for the endogenous opioid system.
    Sandyk R
    Med Hypotheses; 1986 Jan; 19(1):71-4. PubMed ID: 2871480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):269-77. PubMed ID: 2858951
    [No Abstract]   [Full Text] [Related]  

  • 8. Brain iron, dopamine receptor sensitivity, and tardive dyskinesia.
    Blinder BJ; Goodman S; Youdim MB
    Am J Psychiatry; 1986 Feb; 143(2):277-8. PubMed ID: 2868669
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroleptic-opioid interaction: relevance to tardive dyskinesia.
    Sandyk R
    Int J Neurosci; 1986 Aug; 30(1-2):33-6. PubMed ID: 2875043
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of melatonin in the antipsychotic and motor-side effects of neuroleptics: a hypothesis.
    Sandyk R; Kay SR; Gillman MA
    Int J Neurosci; 1992; 64(1-4):203-7. PubMed ID: 1364141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotransmitter interactions related to central dopamine neurons.
    Lloyd KG
    Essays Neurochem Neuropharmacol; 1978; 3():129-207. PubMed ID: 30628
    [No Abstract]   [Full Text] [Related]  

  • 12. Tardive dyskinesia: a biological appraoch.
    Barbaccia ML; Trabucchi M
    Prog Clin Biol Res; 1980; 39():181-93. PubMed ID: 6105670
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroleptic drugs: how to reduce the risk of tardive dyskinesia.
    DeVeaugh-Geiss J
    Geriatrics; 1979 Jul; 34(7):59-61, 66. PubMed ID: 36330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dyskinesia presenting as gastrointestinal disorder.
    Goldberg RJ; Morris PL; Lidofsky S
    J Clin Psychiatry; 1990 Jun; 51(6):253-4. PubMed ID: 1971823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia.
    Reynolds GP
    Acta Psychiatr Scand Suppl; 1994; 380():36-40. PubMed ID: 7914046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic drugs and their action on different neuronal pathways.
    Ungerstedt U; Herrera-Marschitz M; Forster C
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathophysiology of tardive dyskinesia.
    Klawans HL; Carvey P; Tanner CM; Goetz CG
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tardive dyskinesia in psychogeriatric patients: a five-year follow-up.
    Mehta D; Mehta S; Mathew P
    J Am Geriatr Soc; 1977 Dec; 25(12):545-7. PubMed ID: 21899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tardive dyskinesia, dopamine receptors, and neuroleptic damage to cell membranes.
    Seeman P
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):3S-9S. PubMed ID: 2906067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiopathology and curative treatment of tardive dyskinesia].
    Wolf MA; Gautier J
    Encephale; 1987; 13(5):301-8. PubMed ID: 2892663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.